61. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probesStane Pajk, Damijan Knez, Urban Košak, Maja Zorović, Xavier Brazzolotto, Nicolas Coquelle, Florian Nachon, Jacques-Philippe Colletier, Marko Živin, Jure Stojan, Stanislav Gobec, 2020, original scientific article Keywords: butyrylcholinesterase, inhibitor, probe, fluorescence Full text (file, 1,60 MB) This document has more files! More... |
62. Fragment-sized and bidentate (immuno)proteasome inhibitors derived from cysteine and threonine targeting warheadsLevente Kollár, Martina Gobec, Matic Proj, Lara Smrdel, Damijan Knez, Stanislav Gobec, Izidor Sosič, György Keserü M., 2021, original scientific article Keywords: immunoproteasome, benzoxazole-2-carbonitriles, bidentate covalent inhibitors, fragments, non-covalent recognition Full text (file, 1,17 MB) This document has more files! More... |
63. Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitorMaja Zakošek, Sonja Prpar Mihevc, Malan Štrbenc, Urban Košak, Ilija German Ilić, Jurij Trontelj, Simon Žakelj, Stanislav Gobec, Darja Pavlin, Gregor Majdič, 2021, original scientific article Keywords: Alzheimer’s disease, butyrylcholinesterase, butyrylcholinesterase inhibitor, canine cognitive dysfunction, canine dementia scale, dogs Full text (file, 1,34 MB) This document has more files! More... |
|
|
|
67. Synthesis, molecular modelling and biological evaluation of novel heterodimeric, multiple ligands targeting cholinesterases and amyloid betaMichalina Hebda, Marek Bajda, Anna Więckowska, Natalia Szałaj, Anna Pasieka, Dawid Panek, Justyna Godyń, Tomasz Wichur, Damijan Knez, Stanislav Gobec, Barbara Malawska, 2016, original scientific article Keywords: cholinesterase inhibitors, molecular modelling, β-amyloid aggregation inhibitors, Alzheimer’s disease, multi-target-directed ligands (MTDL), PAMPA-BBB assay Full text (file, 3,87 MB) This document has more files! More... |
68. Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's diseaseYoussef Dgachi, Oscar M. Bautista-Aguilera, Mohamed Benchekroun, Hélène Martin, Alexandre Bonet, Damijan Knez, Justyna Godyń, Barbara Malawska, Stanislav Gobec, Mourad Chioua, Jana Janockova, Ondrej Soukup, Fakher Chabchoub, José Marco-Contelles, Lhassane Ismaili, 2016, original scientific article Keywords: Alzheimer's disease, quinazolinones, multicomponent reactions, multitarget-directed ligands, antioxidants, cholinesterase inhibitors, hepatotoxicity Full text (file, 1,47 MB) This document has more files! More... |
69. Discovery of immunoproteasome inhibitors using large-scale covalent virtual screeningAndrea Scarpino, Dávid Bajusz, Matic Proj, Martina Gobec, Izidor Sosič, Stanislav Gobec, György G. Ferenczy, György Keserü M., 2019, original scientific article Keywords: immunoproteasome, covalent inhibitor, virtual screening, β5i selective inhibitor Full text (file, 3,77 MB) This document has more files! More... |
70. 4-phenethyl-1-propargylpiperidine-derived dual inhibitors of butyrylcholinesterase and monoamine oxidase BTjaša Mazej, Damijan Knez, Anže Meden, Stanislav Gobec, Matej Sova, 2021, original scientific article Keywords: Alzheimer's disease, butyrylcholinesterase, monoamine oxidase B, inhibitors, multi-target-directed ligands, multifunctional ligands Full text (file, 3,88 MB) This document has more files! More... |